FindTrial
Sign In

A Comparison of myopia control efficacy in Chinese children with myopia control spectacles (MCS) and combined MCS and atropine

A Comparison of myopia control efficacy in Chinese children with myopia control spectacles (MCS) and combined MCS and atropine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108080
Enrollment
Unknown
Registered
2025-08-25
Start date
2025-09-30
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Experimental group:MCS combined with 0.01%atropine
Control group:MCS

Sponsors

West hospital, Sichuan univerisity
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age: 6~12 years old; 2. Myopia in both eyes: -5.75 D ~ -0.50 D (equivalent spherical magnology >= -5.75); 3. Astigmatism diopter in both eyes = 20/25; 6. Good eye health; 7. Normal binocular visual function.

Exclusion criteria

Exclusion criteria: 1. Suffering from eye diseases such as keratoconjunctivitis, glaucoma, strabismus, etc.; 2. Other myopia control methods have been used, such as OK lenses, atropine, and defocus glasses; 3. Poor compliance and inability to follow up on time; 4. Refuse randomization.

Design outcomes

Primary

MeasureTime frame
Axial length;Spherical equivalent refraction;—

Secondary

MeasureTime frame
Best corrected visual acuity;Contrast sensitivity test;—

Countries

China

Contacts

Public ContactYang Bi

West hospital, Sichuan univerisity

53587134@qq.com+86 136 8840 4467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026